Longitudinal rate of change in CSF biomarkers is associated with subsequent tau PET burden in Braak stages I and II: Findings from the BIOCARD study

Abstract

Background: Alzheimer's disease (AD) is characterized by the accumulation of amyloid‐beta (Aβ) and tau in the brain, years before the onset of cognitive symptoms.